InterOcean Capital’s iShares Biotechnology ETF IBB Stock Holding History

InterOcean Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,625	Closed	-$316K	–	191
2019 Q4	$316K	Hold	2,625	–	–	0.02%	161
2019 Q3	$261K	Hold	2,625	–	–	0.02%	171
2019 Q2	$286K	Sell	2,625 -210	-7%	-$22.3K	0.03%	153
2019 Q1	$317K	Sell	2,835 -105	-4%	-$11.5K	0.03%	145
2018 Q4	$284K	Buy	2,940 +315	+12%	+$33.4K	0.03%	153
2018 Q3	$320K	Sell	2,625 -285	-10%	-$33.6K	0.03%	154
2018 Q2	$320K	Sell	2,910 -370	-11%	-$39.6K	0.04%	158
2018 Q1	$350K	Buy	+3,280	New	+$364K	0.05%	130

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

InterOcean Capital's IBB Position: Q1 2020 in Review

InterOcean Capital sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 2,625 shares — an estimated $316K sold.

InterOcean Capital first reported a position in IBB in Q1 2018 and held it in 8 quarters. The position peaked at $350K in Q1 2018. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

InterOcean Capital reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
InterOcean Capital sold 2,625 iShares Biotechnology ETF shares in Q1 2020, an estimated $316K.
InterOcean Capital first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 8 quarters.
InterOcean Capital's iShares Biotechnology ETF position peaked at $350K in Q1 2018.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on InterOcean Capital's 13F filing for Q1 2020, filed 11 May 2020.